Jorge Nieva

19PUBLICATIONS
164CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 08, 2026
Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma.

|Jun 08, 2026
Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.

|Jun 03, 2026
Dietary and Lifestyle Patterns among Young Patients with Lung Cancer: Analysis of Mutation-Specific Phenotypes.

|Apr 13, 2026
Cost comparison of osimertinib plus platinum-pemetrexed versus amivantamab plus lazertinib for the first-line treatment of patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer.

Gilberto de Lima Lopes, Harry Freeman, Emily Procter

|Aug 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Robert L Ferris, Rom S Leidner, Christine H Chung

|Aug 19, 2025
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.

Amin H Nassar, Chul Kim, Tolulope Adeyelu

Pageof 4

Frequent Collaborators

3 joint publications

Balazs Halmos

3 joint publications

Stephen V Liu

3 joint publications

Chul Kim

3 joint publications

Hossein Borghaei